EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 29 / No 8-9 (Août–Septembre 2013) Med Sci (Paris), 29 8-9 (2013) 778-784 References
Free Access
Issue
Med Sci (Paris)
Volume 29, Number 8-9, Août–Septembre 2013
Page(s) 778 - 784
Section Diabète : approches thérapeutiques émergentes
DOI https://doi.org/10.1051/medsci/2013298018
Published online 05 September 2013
  1. Bouatia-Naji N, Bonnefond A, Froguel P. Avancées dans la génétique de la glycémie à jeun : quelles leçons pour le diabète ? Med Sci (Paris) 2009 ; 25 : 897–902. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Bonnefond A, Froguel P, Vaxillaire M. The emerging genetics of type 2 diabetes. Trends Mol Med 2010 ; 16 : 407–416. [CrossRef] [PubMed] [Google Scholar]
  3. Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet 2009 ; 41 : 77–81. [CrossRef] [PubMed] [Google Scholar]
  4. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009 ; 41 : 89–94. [CrossRef] [PubMed] [Google Scholar]
  5. Lyssenko V, Nagorny CL, Erdos MR, et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009 ; 41 : 82–88. [CrossRef] [PubMed] [Google Scholar]
  6. Sparso T, Bonnefond A, Andersson E, et al. G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19, 605 Europeans. Diabetes 2009 ; 58 : 1450–1456. [CrossRef] [PubMed] [Google Scholar]
  7. Xia Q, Chen ZX, Wang YC, et al. Association between the melatonin receptor 1B gene polymorphism on the risk of type 2 diabetes, impaired glucose regulation: a meta-analysis. PLoS One 2012 ; 7 : e50107. [CrossRef] [PubMed] [Google Scholar]
  8. Kelliny C, Ekelund U, Andersen LB, et al. Common genetic determinants of glucose homeostasis in healthy children: the European youth heart study. Diabetes 2009 ; 58 : 2939–2945. [CrossRef] [PubMed] [Google Scholar]
  9. Barker A, Sharp SJ, Timpson NJ, et al. Association of genetic loci with glucose levels in childhood and adolescence: a meta-analysis of over 6, 000 children. Diabetes 2011 ; 60 : 1805–1812. [CrossRef] [PubMed] [Google Scholar]
  10. Walford GA, Green T, Neale B, et al. Common genetic variants differentially influence the transition from clinically defined states of fasting glucose metabolism. Diabetologia 2012 ; 55 : 331–339. [CrossRef] [PubMed] [Google Scholar]
  11. Langenberg C, Pascoe L, Mari A, et al. Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response. Diabetologia 2009 ; 52 : 1537–1542. [CrossRef] [PubMed] [Google Scholar]
  12. Liao S, Liu Y, Tan Y, et al. Association of genetic variants of melatonin receptor 1B with gestational plasma glucose level, risk of glucose intolerance in pregnant Chinese women. PLoS One 2012 ; 7 : e40113. [CrossRef] [PubMed] [Google Scholar]
  13. Mao H, Li Q, Gao S., Meta-analysis of the relationship between common type 2 diabetes risk gene variants with gestational diabetes mellitus. PLoS One 2012 ; 7 : e45882. [CrossRef] [PubMed] [Google Scholar]
  14. Bonnefond A, Clement N, Fawcett K, et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet 2012 ; 44 : 297–301. [CrossRef] [PubMed] [Google Scholar]
  15. Lebon G, Tate CG. Les récepteurs couplés aux protéines G dans la lumière. Med Sci (Paris) 2012 ; 28 : 876–882. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  16. Simonneaux V. Naughty melatonin: how mothers tick off their fetus. Endocrinology 2011 ; 152 : 1734–1738. [CrossRef] [PubMed] [Google Scholar]
  17. Peschke E, Peschke D. Evidence for a circadian rhythm of insulin release from perifused rat pancreatic islets. Diabetologia 1998 ; 41 : 1085–1092. [CrossRef] [PubMed] [Google Scholar]
  18. Huang W, Ramsey KM, Marcheva B, Bass J. Circadian rhythms, sleep, and metabolism. J Clin Invest 2011 ; 121 : 2133–2141. [CrossRef] [PubMed] [Google Scholar]
  19. Marcheva B, Ramsey KM, Buhr ED, et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 2010 ; 466 : 627–631. [CrossRef] [PubMed] [Google Scholar]
  20. Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010 ; 42 : 105–116. [CrossRef] [PubMed] [Google Scholar]
  21. Woon PY, Kaisaki PJ, Braganca J, et al. Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes. Proc Natl Acad Sci USA 2007 ; 104 : 14412–14417. [CrossRef] [Google Scholar]
  22. Dubocovich ML, Delagrange P, Krause DN, et al. International union of basic and clinical pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev 2010 ; 62 : 343–380. [CrossRef] [PubMed] [Google Scholar]
  23. Diao J, Asghar Z, Chan CB, Wheeler MB. Glucose-regulated glucagon secretion requires insulin receptor expression in pancreatic alpha-cells. J Biol Chem 2005 ; 280 : 33487–33496. [CrossRef] [PubMed] [Google Scholar]
  24. Ramracheya RD, Muller DS, Squires PE, et al. Function and expression of melatonin receptors on human pancreatic islets. J Pineal Res 2008 ; 44 : 273–279. [CrossRef] [PubMed] [Google Scholar]
  25. Peschke E, Stumpf I, Bazwinsky I, et al. Melatonin and type 2 diabetes–a possible link? J Pineal Res 2007 ; 42 : 350–358. [CrossRef] [PubMed] [Google Scholar]
  26. Jockers R, Maurice P, Boutin JA, Delagrange P. Melatonin receptors, heterodimerization, signal transduction and binding sites: what’s new? Br J Pharmacol 2008 ; 154 : 1182–1195. [CrossRef] [PubMed] [Google Scholar]
  27. Petit L, Lacroix I, de Coppet P, et al. Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3’-5’-monophosphate pathway. Biochem Pharmacol 1999 ; 58 : 633–639. [CrossRef] [PubMed] [Google Scholar]
  28. Bahr I, Muhlbauer E, Albrecht E, Peschke E. Evidence of the receptor-mediated influence of melatonin on pancreatic glucagon secretion via the Galphaq protein-coupled and PI3K signaling pathways. J Pineal Res 2012 ; 53 : 390–398. [CrossRef] [PubMed] [Google Scholar]
  29. Samols E, Marri G, Marks V. Interrelationship of glucagon, insulin and glucose. The insulinogenic effect of glucagon. Diabetes 1966 ; 15 : 855–866. [PubMed] [Google Scholar]
  30. Nagorny CL, Sathanoori R, Voss U, et al. Distribution of melatonin receptors in murine pancreatic islets. J Pineal Res 2011 ; 50 : 412–417. [CrossRef] [PubMed] [Google Scholar]
  31. Franc C. Le diabète : des chiffres alarmants. Med Sci (Paris) 2013 ; 29 : 711–714. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  32. Duez H, Sebti Y, Staels B. Horloges circadiennes et métabolisme : intégration des signaux métaboliques et environnementaux. Med Sci (Paris) 2013 ; 29 : 772–777. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  33. Vieira A, Druelle N, Courtney M, et al. Reprogrammation des cellules pancréatiques en cellules b. Med Sci (Paris) 2013 ; 29 : 749–755. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.